IP Library Granted Patent US 10,799,622
Granted Patent B2
US 10,799,622 · App. 16/180,637 · Granted Oct 13, 2020

Reducing post-operative adhesion formation with intraperitoneal glutamine

Inventor: Adebola O. E. Obayan (Saskatoon, CA)
Assignee: Ade Therapeutics, Inc.
A61L31/16A61K9/0019A61K9/0024A61K9/12A61K31/198A61K38/05A61L31/047A61L31/10A61L31/145A61L31/148A61L2300/214A61L2300/25A61L2300/252A61L2300/412A61L2300/424
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,799,622
App. No.
16/180,637
Granted
Oct 13, 2020
Kind
B2
Abstract

The present disclosure relates to a method of treating or reducing adhesions in the peritoneum of a patient in need thereof. The method includes performing adhesiolysis on one or more adhesions involving the patient's peritoneum and/or one or more tissues or organs in the patient's peritoneal cavity; and administering to the peritoneum or the peritoneal cavity of the patient an effective amount of a composition comprising at least one glutamine source. The glutamine source is selected from one or more of L-glutamine, physiologically acceptable salts of L-glutamine, and dipeptides comprising L-glutamine.

Claims (12)

1. A method of treating or reducing adhesions in the peritoneum of a patient in need thereof, comprising:

(a) performing adhesiolysis on one or more adhesions involving the patient's peritoneum and/or one or more tissues or organs in the patient's peritoneal cavity; and

(b) administering to the peritoneum or the peritoneal cavity of the patient an effective amount of a composition comprising at least one glutamine source;

wherein the glutamine source is a dipeptide selected from alanyl-glutamine and glycyl-glutamine.

2. The method of claim 1 , wherein the dipeptide is alanyl-glutamine.

3. The method of claim 1 , wherein the glutamine residue of the dipeptide is at the C-terminus of the dipeptide.

4. The method of claim 3 , wherein the glutamine residue is L-glutamine.

5. The method of claim 1 , wherein the composition is selected from the group consisting of a liquid composition, a paste composition, and a gel composition.

6. The method of claim 5 , wherein the liquid composition is a sterile aqueous composition.

7. The method of claim 1 , wherein the composition is impregnated in a surgical material.

8. The method of claim 7 , wherein the surgical material is a mesh.

9. The method of claim 5 , wherein the gel composition is a hydrogel.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2020
From: OBAYAN, ADEBOLA O.E.
To: INDUSTRY LIAISON OFFICE, UNIVERSITY OF SASKATCHEWAN (ILO)
Reel/Frame 052419/0568 →
CHANGE OF NAME Recorded Apr 16, 2020
From: INDUSTRY LIAISON OFFICE, UNIVERSITY OF SASKATCHEWAN (ILO)
To: UNIVERSITY OF SASKATCHEWAN
Reel/Frame 052419/0579 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2020
From: UNIVERSITY OF SASKATCHEWAN
To: ADETHERAPEUTICS, INC.
Reel/Frame 052419/0604 →
Continuity (6)
Continuation 15480148 · Apr 5, 2017
Continuation 14660382 · Mar 17, 2015
Continuation 13779362 · Feb 27, 2013
Continuation 12063423
Provisional Application 60707173 · Aug 11, 2005
Related Publication 20190111189A1 · Apr 18, 2019